0001127602-24-013490.txt : 20240426
0001127602-24-013490.hdr.sgml : 20240426
20240426173357
ACCESSION NUMBER: 0001127602-24-013490
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240425
FILED AS OF DATE: 20240426
DATE AS OF CHANGE: 20240426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Louie Ngar Yee
CENTRAL INDEX KEY: 0001913264
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41455
FILM NUMBER: 24885500
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAIA Biotechnology, Inc.
CENTRAL INDEX KEY: 0001878313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
BUSINESS PHONE: 312-416-8592
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-04-25
0001878313
MAIA Biotechnology, Inc.
MAIA
0001913264
Louie Ngar Yee
444 WEST LAKE STREET, SUITE 1700
CHICAGO
IL
60606
1
0
Common Stock
2024-04-25
4
P
0
19665
2.03
A
1167189
D
Warrants
2.26
2024-04-25
4
P
0
19665
2.26
A
2024-10-25
2029-10-25
Common Stock
19665
19665
D
The common stock was purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on April 25, 2024.
The warrants were purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were deemed options issued under the Issuer's 2021 Equity Inventive Plan on April 25, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date.
/s/ Louie Ngar Yee
2024-04-26